Recombinant protein rMBP-NAP restricts tumor progression by triggering antitumor immunity in mouse metastatic lung cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant protein rMBP-NAP restricts tumor progression by triggering antitumor immunity in mouse metastatic lung cancer
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Volume 96, Issue 2, Pages 113-119
Publisher
Canadian Science Publishing
Online
2017-09-02
DOI
10.1139/cjpp-2017-0186
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma
- (2015) J Y Liu et al. BRITISH JOURNAL OF CANCER
- Antitumor and immunomodulatory effects of recombinant fusion protein rMBP-NAP through TLR-2 dependent mechanism in tumor bearing mice
- (2015) Ting Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10
- (2014) Filipe M de Melo et al. IMMUNOLOGY AND CELL BIOLOGY
- IL-27 Activates Human Trophoblasts to Express IP-10 and IL-6: Implications in the Immunopathophysiology of Preeclampsia
- (2014) Nanlin Yin et al. MEDIATORS OF INFLAMMATION
- An Infection-enhanced Oncolytic Adenovirus Secreting H. pylori Neutrophil-activating Protein with Therapeutic Effects on Neuroendocrine Tumors
- (2013) Mohanraj Ramachandran et al. MOLECULAR THERAPY
- Inflammatory chemokines and metastasis—tracing the accessory
- (2013) L Borsig et al. ONCOGENE
- IL-27 in tumor immunity and immunotherapy
- (2013) Gopal Murugaiyan et al. TRENDS IN MOLECULAR MEDICINE
- Polyinosinic-Polycytidylic Acid Limits Tumor Outgrowth in a Mouse Model of Metastatic Lung Cancer
- (2012) G. Forte et al. JOURNAL OF IMMUNOLOGY
- Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus
- (2012) Ianko D Iankov et al. MOLECULAR THERAPY
- HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response
- (2011) Gaia Codolo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lung cancer and Toll-like receptors
- (2011) Aldo Pinto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
- (2011) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
- (2009) W. K. Nevala et al. CLINICAL CANCER RESEARCH
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Immune escape as a fundamental trait of cancer: focus on IDO
- (2008) G C Prendergast ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started